Metrocare tablets 250 mg
Metrocare tablets 250 mg
Authorised
- Metronidazole
Product identification
Medicine name:
Metrocare tablets 250 mg
Metrocare 250 mg Comprimé
Metrocare 250 mg Tablette
Metrocare 250 mg Tablet
Active substance:
- Metronidazole
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Metronidazole250.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XD01
- QP51AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- PVC Aluminium Oriented polyamide Aluminium blister packs.Cardboard box of 7 blisters. Pack size 70 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 9 blisters. Pack size 90 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 8 blisters. Pack size 80 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 6 blisters. Pack size 60 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 50 blisters. Pack size 500 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 5 blisters. Pack size 50 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 4 blisters. Pack size 40 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 3 blisters. Pack size 30 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 25 blisters. Pack size 250 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 2 blisters. Pack size 20 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 10 blisters. Packsize 100 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 1 blister. Pack size 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V545404
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0239/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Hungary
-
Ireland
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: